SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0001140361-18-045590
Filing Date
2018-12-21
Accepted
2018-12-21 14:20:31
Documents
15

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 4752733
2 logo_nanobiotix.jpg GRAPHIC 19694
3 s002598x1_graphic2.jpg GRAPHIC 148588
4 s002598x1_graphic1.jpg GRAPHIC 181116
5 s002598x1_graphic3.jpg GRAPHIC 199496
6 s002598x1_graphic4.jpg GRAPHIC 281066
7 s002598x1_graphic5.jpg GRAPHIC 111915
8 s002598x1_graphic6.jpg GRAPHIC 126550
9 s002598x1_graphic7.jpg GRAPHIC 136072
10 s002598x1_graphic8.jpg GRAPHIC 168689
11 s002598x1_graphic9.jpg GRAPHIC 105370
12 s002598x1_graphic10.jpg GRAPHIC 153841
13 s002598x1_graphic11.jpg GRAPHIC 286357
14 s002598x1_graphic12.jpg GRAPHIC 127144
15 s002598x1_graphic13.jpg GRAPHIC 107051
  Complete submission text file 0001140361-18-045590.txt   7700094
Mailing Address 60 RUE DE WATTIGNIES PARIS I0 75012
Business Address 60 RUE DE WATTIGNIES PARIS I0 75012 33140260470
Nanobiotix S.A. (Filer) CIK: 0001760854 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-02433 | Film No.: 181248957
SIC: 2834 Pharmaceutical Preparations